Johnson & Johnson (JNJ)
146.67
+1.39
(+0.96%)
USD |
NYSE |
May 31, 16:00
146.79
+0.12
(+0.08%)
After-Hours: 20:00
Johnson & Johnson Cash and Short Term Investments (Annual): 22.93B for Dec. 31, 2023
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.93B |
| December 31, 2022 | 22.28B |
| December 31, 2021 | 31.61B |
| December 31, 2020 | 25.18B |
| December 31, 2019 | 19.29B |
| December 31, 2018 | 19.69B |
| December 31, 2017 | 18.30B |
| December 31, 2016 | 41.91B |
| December 31, 2015 | 38.38B |
| December 31, 2014 | 33.09B |
| December 31, 2013 | 29.21B |
| December 31, 2012 | 21.09B |
| December 31, 2011 | 32.26B |
| December 31, 2010 | 27.66B |
| December 31, 2009 | 19.42B |
| December 31, 2008 | 12.81B |
| December 31, 2007 | 9.315B |
| December 31, 2006 | 4.084B |
| December 31, 2005 | 16.14B |
| December 31, 2004 | 12.88B |
| Date | Value |
|---|---|
| December 31, 2003 | 9.523B |
| December 31, 2002 | 7.475B |
| December 31, 2001 | 7.972B |
| December 31, 2000 | 6.757B |
| December 31, 1999 | 3.879B |
| December 31, 1998 | 2.783B |
| December 31, 1997 | 2.753B |
| December 31, 1996 | 2.011B |
| December 31, 1995 | 1.201B |
| December 31, 1994 | 636.00M |
| December 31, 1993 | 372.00M |
| December 31, 1992 | 745.00M |
| December 31, 1991 | 589.00M |
| December 31, 1990 | 826.00M |
| December 31, 1989 | 452.00M |
| December 31, 1988 | 660.00M |
| December 31, 1987 | 741.00M |
| December 31, 1986 | 952.50M |
| December 31, 1985 | 735.60M |
| December 31, 1984 | 442.50M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
19.29B
Minimum
2019
31.61B
Maximum
2021
24.26B
Average
22.93B
Median
2023
Cash and Short Term Investments (Annual) Benchmarks
| Eli Lilly and Co | 2.928B |
| Merck & Co Inc | 7.093B |
| Pfizer Inc | 12.69B |
| AbbVie Inc | 12.82B |
| Shockwave Medical Inc | 990.55M |